Transcription factor Ets1 regulates expression of thioredoxin-interacting protein and inhibits insulin secretion in pancreatic β-cells.

PLoS One

Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry of Education, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.

Published: October 2015


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Long-term activation of extracellular-regulated kinase (ERK1/2) pathway has been shown to cause glucotoxicity and inhibit insulin gene expression in β-cells. Transcription factor Ets1 is activated by ERK1/2-mediated phosphorylation at the Thr38 residue. We hypothesize that Ets1 plays an important role in mediating ERK1/2 induced glucotoxicity in β-cells. We determined the role of Ets1 in Min6 cells and isolated mouse islets using overexpression and siRNA mediated knockdown of Ets1. The results show that Ets1 was localized in insulin-staining positive cells but not in glucagon-staining positive cells. Overexpression of Ets1 reduced glucose-stimulated insulin secretion in primary mouse islets. Overexpression of Ets1 in Min6 β-cells and mouse islets increased expression of thioredoxin-interacting protein (TXNIP). Conversely, knockdown of Ets1 by siRNA reduced expression of TXNIP in Min6 cells. Ets1 was associated with the txnip promoter in min6 cells and transfection of 293 cells with Ets1 and p300 synergistically increased txnip promoter reporter activity. Moreover, overexpression of Ets1 inhibited Min6 cell proliferation. Our results suggest that Ets1, by promoting TXNIP expression, negatively regulates β-cell function. Thus, over-activation of Ets1 may contribute to diet-induced β-cell dysfunction.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045976PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0099049PLOS

Publication Analysis

Top Keywords

ets1
14
min6 cells
12
mouse islets
12
overexpression ets1
12
transcription factor
8
factor ets1
8
expression thioredoxin-interacting
8
thioredoxin-interacting protein
8
insulin secretion
8
ets1 min6
8

Similar Publications

CircPLK1 upregulates ETS1 to confer anthracycline resistance in triple-negative breast cancer.

J Transl Int Med

June 2025

Department of Breast Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong Province, China.

Background And Objectives: Circular RNAs play a vital role in developing triple-negative breast cancer (TNBC). Likewise, the function of circRNAs in TNBC resistance to chemotherapy remains largely unknown. Here, we aimed to investigate whether circPLK1 has a biological efect on anthracycline resistance in TNBC.

View Article and Find Full Text PDF

Atg7 in CD4 T cells improves intestinal mucosal inflammation by regulating Ets1-mediated T cell differentiation.

Clin Transl Med

September 2025

MOE Medical Basic Research Innovation Center for Gut Microbiota and Chronic Diseases, Wuxi School of Medicine, Jiangnan University, Wuxi, People's Republic of China.

Background: Atg7-autophagy-related gene 7 contributes as an immune cell function regulator, particularly involved in CD4⁺ T cell response. Nevertheless, the specific contribution of Atg7 in CD4⁺ T cells sensitive immune responses in inflammatory bowel disease (IBD) remains largely unclear. This study explores the functional significance and regulatory mechanisms of CD4⁺ T cell-specific Atg7 in IBD.

View Article and Find Full Text PDF

Understanding diseases as the result of continuous transitions from a healthy system is more realistic than understanding them as discrete states. Here, we designed the spectrum formation approach (SFA), a machine learning-based method that extracts key features contributing to disease state continuity. We applied the SFA to transcriptomic data from patients with progressive liver disease and neurodegenerative movement disorders to examine its effectiveness in identifying biologically relevant gene sets.

View Article and Find Full Text PDF

Discovery of as a New Gene Predisposing to Dilated Cardiomyopathy.

Diagnostics (Basel)

August 2025

Department of Cardiology, Shanghai Fifth People's Hospital, Fudan University, Shanghai 200240, China.

Dilated cardiomyopathy (DCM), defined as dilation and contractile dysfunction of the left or both cardiac ventricles, remains the most common category of primary myocardial disease worldwide. It is the most prevalent cause of chronic heart failure and the most common indication for cardiac transplantation in young subjects. Accumulating evidence increasingly highlights the substantial genetic defects underlying DCM.

View Article and Find Full Text PDF

Background: Understanding the interplay between genetic risk factors and molecular pathways in rheumatoid arthritis (RA) is essential for developing effective treatments. This study aims to utilize genetic risk factors of RA and identify their key pathways and potential therapeutic targets through an integrated multi-omics approach.

Methods: We developed a computational pipeline to construct a knowledge graph that combines genetic risk factor molecular networks with multi-omics enrichment analysis to estimate potential therapeutic target for RA.

View Article and Find Full Text PDF